glp-1 sglt2 Common systemic effects of either inhibitors or GLP-1R agonists SGLT2 Inhibitors vs. GLP-1 Agonists

Adiponectin levels increased in a time-related manner with higher doses of retatrutide, consistent with progressive adipose tissue reductions and improvements in insulin sensitivity 30

Hypoglycemia: The risk is less with GLP-1 RAs

Phase 3 trials are ongoing, and no regulatory submission has yet been made to the MHRA or EMA

A new positive for junior Springbok prop Kai Pratt, SAIDS rejecting the "witch hunt" framing, and Ross digs into the numbers: testing down more than six-fold in a decade, South Africa accounting for one in five rugby doping cases worldwide, and an anti-doping body whose budget has flatlined

Concerning data from semaglutide trials showed substantially less fat loss than predicted, indicating greater lean mass loss than expected

Both medications can cause side effects such as nausea, vomiting, diarrhea, and constipation, and are typically given as once-weekly injections